-
公开(公告)号:US08507521B2
公开(公告)日:2013-08-13
申请号:US13505349
申请日:2010-11-02
申请人: Julia Adam , Jonathan Gillespie , Steven Laats , John Kinnaird Ferguson MacLean , Duncan Robert McArthur
发明人: Julia Adam , Jonathan Gillespie , Steven Laats , John Kinnaird Ferguson MacLean , Duncan Robert McArthur
IPC分类号: A61K31/437 , A61K31/4439 , A61K31/422 , A61K31/4178 , C07D471/04 , A61P25/22 , C07D401/14 , C07D413/10 , C07D403/10 , C07D405/14 , A61P25/18 , A61K31/4725 , C07D401/10
CPC分类号: C07D401/10 , C07D401/14 , C07D403/10 , C07D405/14 , C07D413/10
摘要: The present invention relates to a heterocyclic derivative of formula (I) wherein the variables are as defined in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention further relates to pharmaceutical compositions comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of disorders mediated by glutamate dysfunction, such as schizophrenia and generalised anxiety disorder.
摘要翻译: 本发明涉及式(I)的杂环衍生物,其中变量如说明书中所定义,或其药学上可接受的盐或溶剂合物。 本发明还涉及包含所述杂环衍生物的药物组合物及其在治疗中的用途,例如用于治疗或预防由谷氨酸盐功能障碍如精神分裂症和广泛性焦虑症介导的障碍。
-
公开(公告)号:US07655645B2
公开(公告)日:2010-02-02
申请号:US12031851
申请日:2008-02-15
申请人: Julia Adam
发明人: Julia Adam
IPC分类号: A61K31/551 , A61K31/496 , C07D413/14 , C07D417/14
CPC分类号: C07D417/04 , C07D413/04
摘要: The invention relates to indole derivative having the general Formula I wherein A represents a 5-membered aromatic heterocyclic ring, wherein X1, X2 and X3 are independently selected from N, O, S and CH; Y represents CH2, O, S or SO2; R1 is H, (C1-4)-alkyl, (C1-4)alkyloxy, CN or halogen; R2, R2′, R3, R3′, R4, R4′, R5 and R5′ are independently hydrogen, (C1-4)alkyl (optionally substituted with OH) or CO—OR8; or one pair of geminal substituents R3 and R3′ or R5 and R5′ together represent a keto group, and the others are all hydrogen or (C1-4)alkyl; or R2 and R5 together represent a methylene or an ethylene bridge, and R2′, R3, R3′, R4, R4′ and R5′ are hydrogen; n is 1 or 2; R6 is H, (C1-4)alkyl (optionally substituted with OH, (C1-4)alkyloxy, CO—NR9R10, CO—OR11 or 1,2,4-oxadiazol-3-yl), SO2NR12R13 or COOR14; R7 is H or halogen; R8 is (C1-4)alkyl; R9 and R10 are independently hydrogen, (C1-4)alkyl or (C3-7)cycloalkyl, the alkyl groups being optionally substituted with OH or (C1-4)alkyloxy; R11 is H or (C1-4)alkyl; R12 and R13 are independently H or (C1-4)alkyl; R14 is (C1-6)alkyl; or a pharmaceutically acceptable salt thereof, as agonists of the cannabinoid CB1 receptor, which can be used in the treatment of pain such as for example peri-operative pain, chronic pain, neuropathic pain, cancer pain and pain and spasticity associated with multiple sclerosis.
摘要翻译: 本发明涉及具有通式I的吲哚衍生物,其中A代表5元芳族杂环,其中X1,X2和X3独立地选自N,O,S和CH; Y表示CH 2,O,S或SO 2; R 1是H,(C 1-4) - 烷基,(C 1-4)烷氧基,CN或卤素; R2,R2',R3,R3',R4,R4',R5和R5'独立地是氢,(C1-4)烷基(任选被OH取代)或CO-OR8; 或一对偕取代基R 3和R 3'或R 5和R 5'一起代表酮基,而其它取代基全部为氢或(C 1-4)烷基; 或者R 2和R 5一起表示亚甲基或乙烯桥,R2',R3,R3',R4,R4'和R5'是氢; n为1或2; R 6是H,(C 1-4)烷基(任选被OH,(C 1-4)烷氧基,CO-NR 9 R 10,CO-OR 11或1,2,4-恶二唑-3-基),SO 2 NR 12 R 13或COOR 14取代; R7是H或卤素; R8是(C1-4)烷基; R 9和R 10独立地为氢,(C 1-4)烷基或(C 3-7)环烷基,所述烷基任选被OH或(C 1-4)烷氧基取代; R11为H或(C1-4)烷基; R 12和R 13独立地为H或(C 1-4)烷基; R14是(C1-6)烷基; 或其药学上可接受的盐作为大麻素CB1受体的激动剂,其可用于治疗疼痛,例如手术前疼痛,慢性疼痛,神经性疼痛,癌症疼痛和与多发性硬化相关的疼痛和痉挛状态。
-
公开(公告)号:US20120220622A1
公开(公告)日:2012-08-30
申请号:US13505349
申请日:2010-11-02
申请人: Julia Adam , Jonathan Gillespie , Steven Laats , John Kinnaird Ferguson MacLean , Duncan Robert McArthur
发明人: Julia Adam , Jonathan Gillespie , Steven Laats , John Kinnaird Ferguson MacLean , Duncan Robert McArthur
IPC分类号: A61K31/437 , A61K31/4439 , A61K31/422 , A61K31/4178 , C07D471/04 , A61P25/22 , C07D401/14 , C07D413/10 , C07D403/10 , C07D405/14 , A61P25/18 , A61K31/4725 , C07D401/10
CPC分类号: C07D401/10 , C07D401/14 , C07D403/10 , C07D405/14 , C07D413/10
摘要: The present invention relates to a heterocyclic derivative of formula (I) wherein the variables are as defined in the specification, or to a pharmaceutically acceptable salt or solvate thereof. The present invention further relates to pharmaceutical compositions comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of disorders mediated by glutamate dysfunction, such as schizophrenia and generalised anxiety disorder.
摘要翻译: 本发明涉及式(I)的杂环衍生物,其中变量如说明书中所定义,或其药学上可接受的盐或溶剂合物。 本发明还涉及包含所述杂环衍生物的药物组合物及其在治疗中的用途,例如用于治疗或预防由谷氨酸盐功能障碍如精神分裂症和广泛性焦虑症介导的障碍。
-
公开(公告)号:US20080207598A1
公开(公告)日:2008-08-28
申请号:US12031851
申请日:2008-02-15
申请人: Julia Adam
发明人: Julia Adam
IPC分类号: A61K31/496 , C07D417/06 , A61K31/551 , A61P25/00 , C07D243/08
CPC分类号: C07D417/04 , C07D413/04
摘要: The invention relates to indole derivative having the general Formula I wherein A represents a 5-membered aromatic heterocyclic ring, wherein X1, X2 and X3 are independently selected from N, O, S and CH; Y represents CH2, O, S or SO2; R1 is H, (C1-4)-alkyl, (C1-4)alkyloxy, CN or halogen; R2, R2′, R3, R3′, R4, R4′, R5 and R5′ are independently hydrogen, (C1-4)alkyl (optionally substituted with OH) or CO—OR8; or one pair of geminal substituents R3 and R3′ or R5 and R5′ together represent a keto group, and the others are all hydrogen or (C1-4)alkyl; or R2 and R5 together represent a methylene or an ethylene bridge, and R2′, R3, R3′, R4, R4′ and R5′ are hydrogen; n is 1 or 2; R6 is H, (C1-4)alkyl (optionally substituted with OH(C1-4)alkyloxy, CO—NR9R10, CO—OR11 or 1,2,4-oxadiazol-3-yl), SO2NR12R13 or COOR14; R7 is H or halogen; R8 is (C1-4)alkyl; R9 and R10 are independently hydrogen, (C1-4)alkyl or (C3-7)cycloalkyl, the alkyl groups being optionally substituted with OH or (C1-4)alkyloxy; R11 is H or (C1-4)alkyl; R12 and R13 are independently H or (C1-4)alkyl; R14 is (C1-6)alkyl; or a pharmaceutically acceptable salt thereof, as agonists of the cannabinoid CB1 receptor, which can be used in the treatment of pain such as for example peri-operative pain, chronic pain, neuropathic pain, cancer pain and pain and spasticity associated with multiple sclerosis.
-
-
-